Biomarker identified in systemic sclerosis predicts progression

Biomarker identified in systemic sclerosis predicts progression

(HealthDay)—Patients with systemic sclerosis have elevated levels of CXCL4, which predicts disease risk and progression, according to a study published online Dec. 18 in the New England Journal of Medicine.

Lenny van Bon, M.D., from the Boston University School of Medicine, and colleagues performed proteome-wide analysis using isolated from healthy individuals and from patients with systemic sclerosis with distinct clinical phenotypes. The findings were validated in five large cohorts of patients with systemic sclerosis, and were compared with those for patients with systemic lupus erythematosus, ankylosing spondylitis, and hepatic fibrosis.

The researchers found that, in systemic sclerosis, the predominant protein secreted by plasmacytoid dendritic cells in circulation and in skin was CXCL4, with a mean level of 25,624 pg/mL, which was significantly higher than that found in controls (92.5 pg/mL) or in patients with (1,346 pg/mL), ankylosing spondylitis (1,368 pg/mL), or liver fibrosis (1,668 pg/mL). There was a correlation between CXCL4 levels and skin and lung fibrosis and pulmonary arterial hypertension. Of the chemokines, only CXCL4 predicted systemic sclerosis risk and progression. CXCL4 induced inflammatory cell influx and skin transcriptome changes in vivo.

"Levels of CXCL4 were elevated in patients with and correlated with the presence and progression of complications, such as lung fibrosis and ," the authors write.

More information: Full Text

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Where Ebola battles are won

7 hours ago

(HealthDay)—Four hospitals that are home to advanced biocontainment facilities have become America's ground zero in the treatment of Ebola patients.

Depression tied to worse lumbar spine surgery outcomes

9 hours ago

(HealthDay)—Depressive symptoms are associated with poorer long-term outcome in patients undergoing surgery for lumbar spinal stenosis (LSS), according to research published in the Oct. 1 issue of The Sp ...

Ebola death toll edging to 4,900 mark: WHO

10 hours ago

The death toll in the world's worst-ever Ebola outbreak has edged closer to 4,900, while almost 10,000 people have now been infected, new figures from the World Health Organization showed Wednesday.

US to track everyone coming from Ebola nations

10 hours ago

U.S. authorities said Wednesday that everyone traveling into the U.S. from Ebola-stricken nations will be monitored for symptoms for 21 days. That includes returning American aid workers, federal health employees ...

User comments